Table 4.
Nonpharmacological interventions for people with Parkinson's and cognitive impairment | ||||
---|---|---|---|---|
Population: People with idiopathic Parkinson's disease and cognitive impairment | ||||
Setting: Any | ||||
Intervention: Nonpharmacological interventions (only cognitive interventions represented by meta-analysis) | ||||
Comparison: Control arm (varied comparators: Usual care; physical activity/rehabilitation; cognitive training) | ||||
Outcomes
Immediately postintervention (up to 2 weeks post end of intervention) |
Comparative risks: Standardised mean difference (95% Cis) | No. of participants (studies) | Quality of the evidence (Grade) | Comments |
Health-related quality of life
PDQ-39, PDQ-8, Qualidem |
−0.20 [−0.57, 0.18] | 235 (7∗) | ⊕⃝⃝⃝ Very lowa,b,c,d |
Negative values indicate improved health-related quality of life (signs reversed for Qualidem to match direction of effect). |
Function/Activities of daily Living
Bayer ADLs, BAFQ, UPDRS Part II, pill questionnaire |
0.14 [−0.23, 0.51] | 200 (5∗) | ⊕⃝⃝⃝ Very lowa,b,c,d |
Positive values indicate worsened function. |
Wellbeing
Relatives stress scale, brief resilience scale, generalised efficacy scale |
See comment | 105 (2) | ⊕⃝⃝⃝ Very low |
Outcomes address different aspects of wellbeing rather than a unified construct and so not considered suitable for meta-analysis. |
∗One study is divided into two independent intervention arms, with the control group halved for inclusion in the meta-analysis.
aDowngraded by one point due to the risk of bias of included studies: risk about randomisation in two trials, risk from crossover (carryover) in one, risk about outcome measurement due to lack of blinding (expected due to nature of interventions) in 5 of the 7 trials included in HrQoL analysis, and 2 of the 4 for function analysis.
bDowngraded by one point due to inconsistency: moderate heterogeneity. Some can be accounted for by subgroup analysis by intervention type, comparator type and cognitive diagnosis of participants.
cDowngraded by one point due to imprecision: confidence intervals cross two possible interpretations (benefit and harm).
dDowngraded by one point due to detection of publication bias on funnel plot where possible and extrapolated when too few studies for funnel plot.